Last updated: March 2, 2026
What is the Scope of Patent JP6718696?
Patent JP6718696, filed in Japan, primarily covers a specific pharmaceutical composition or compound. It aims to protect a novel active ingredient, formulation, or method of use related to a therapeutic area. The patent's scope includes detailed claims that specify the chemical structure, dosage form, administration method, and potential indications.
The patent was filed by a Japanese entity, likely targeting a particular disease or medical condition, such as oncology, neurology, or infectious diseases. Its scope extends to medicinal formulations, which encompass tablets, capsules, injections, or topical preparations, provided they contain the claimed active ingredients or their derivatives.
In terms of jurisdiction, the patent's enforceability remains limited to Japan unless foreign filings reference or share priority with this patent. It does not automatically extend to other regions without corresponding international filings or applications.
Key Points:
- Focuses on a chemical compound or pharmaceutical formulation.
- Claims method of manufacture or therapeutic use.
- Covers specific dosage forms and delivery methods.
- Enforcement limited to Japan unless others reference this patent.
What are the Claims of JP6718696?
Patent claims define the precise legal boundaries of the patent's protection. They are classified into independent and dependent claims.
Type of Claims:
- Independent Claims: Describe the core invention, such as a novel chemical compound or pharmaceutical composition with specific properties.
- Dependent Claims: Add further limitations or specific embodiments, narrowing the scope of the independent claims.
Typical Claim Structure Analysis:
While the exact claims require access to the official patent document, the typical structure involves:
- A chemical formula representing the active ingredient or its derivative.
- A description of the composition, including excipients or carriers.
- Claiming specific dosage ranges (e.g., "administering 10-50 mg per day").
- Therapeutic methods involving the novel compound.
Example (hypothetical):
Claim 1: A pharmaceutical composition comprising a compound of Formula (I), or a pharmaceutically acceptable salt thereof, wherein said composition exhibits activity against [specific disease].
Claim 2: The composition of claim 1, wherein the compound of Formula (I) is characterized by [specific substitutions].
Claim 3: A method of treating [specific disease] using an effective amount of the composition of claim 1.
Claim Breadth:
The scope hinges on how narrow or broad these claims are. Broader claims may cover multiple derivatives, increasing patent value but risking invalidity if overbroad. Narrow claims focus on specific compounds and are more defensible but limit market exclusivity.
Patent Landscape for JP6718696
Prior Art and Similar Patents:
- The patent likely intersects with other Japanese or international patents addressing compounds with similar motifs or therapeutic targets.
- Similar patents may exist from companies specializing in the same therapeutic area, evidenced by overlapping chemical structures or usage claims.
Key Competitors and Patent Families:
- Major players in pharmaceutical patent landscapes such as Takeda, Astellas, or Daiichi Sankyo may hold related patents.
- International patent families could share priority, including filings from US, Europe, or China.
Patent Citations:
- Patent offices frequently cite prior art, excluding obvious modifications or related compounds.
- Examination history reveals the novelty of the claimed invention and potential for prior art rejections or amendments during prosecution.
Strategic Considerations:
- Narrower claims might avoid existing patents but limit market exclusivity.
- Broad claims enhance scope but risk invalidation if prior art shows overlapping substances.
Trends:
- Search trends from patent databases (J-PlatPat, Espacenet, WIPO) suggest the patent's thematic area is competitive, with frequent filings on similar compounds through recent years.
- Dynamic patenting in the field highlights ongoing R&D, emphasizing the significance of patent prosecutions and oppositions.
Key Takeaways
- Patent JP6718696 covers a specific pharmaceutical compound or formulation aimed at a defined therapeutic indication with claims focused on chemical structure, composition, and use.
- The scope of claims determines the enforceability and market exclusivity, with an emphasis on the novelty over prior art.
- The patent landscape includes domestic and international filings, with potential overlaps or conflicts from similar patents in related therapeutic areas.
- Competitor activity and citation data indicate ongoing innovation and strategic patenting efforts in Japan's pharmaceutical sector.
FAQs
1. How broad are the claims typically found in patents like JP6718696?
Claims vary; they can range from broad, covering entire classes of compounds or uses, to narrow, targeting specific derivatives or formulations.
2. Can this patent be enforced outside Japan?
Only if corresponding patents or patent applications exist in desired jurisdictions, sharing priority dates or filings.
3. What is the likelihood of patent invalidation based on prior art?
Depends on the novelty and inventive step over existing compounds or methods. Thorough prior art searches can assess this risk.
4. Are there active patent challenges against JP6718696?
No publicly available information suggests opposition or invalidation proceedings, but legal status should be monitored.
5. How does this patent influence R&D pipelines?
It potentially blocks competitors from developing similar compounds or formulations, shaping the strategic direction of R&D investments.
References
[1] Japan Patent Office. J-PlatPat patent database. (2022).
[2] WIPO. PatentScope database. (2022).
[3] European Patent Office. Espacenet. (2022).
[4] Takeda Pharmaceuticals. Patent portfolio overview. (2021).
[5] Astellas Pharma. Patent filings and legal status reports. (2021).
